単位用量製造の世界市場

単位用量製造の世界市場は2030年までに1,348億米ドルに到達

2024年に767億米ドルと推定される単位用量製造の世界市場は、2024年から2030年にかけてCAGR 9.9%で成長し、2030年には1,348億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つであるインハウスは、CAGR 8.5%を記録し、分析期間終了時には817億米ドルに達すると予測されています。アウトソーシング分野の成長率は、分析期間中CAGR 12.2%と推定されます。

米国市場は209億米ドル、中国はCAGR13.2%で成長予測

米国の単位用量製造市場は2024年に209億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに272億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.2%と8.6%と予測されています。欧州では、ドイツがCAGR 7.7%で成長すると予測されています。

世界の単位用量製造市場- 主要動向と促進要因のまとめ

精密投与へのシフトが医薬品包装の展望を再定義？

医薬品の安全性、投薬の正確性、規制遵守が重視されるようになり、製薬・ヘルスケア分野での単位用量製造の採用が急速に進んでいます。単位用量包装は、個別に包装され、ラベルが貼られた医薬品の用量で、通常、1回使い切り用に設計されており、患者の安全性を高め、投薬ミスのリスクを低減します。この形式は、正確な調剤が治療成績の向上と薬物有害事象の最小化に重要な役割を果たす病院や長期療養環境において特に重要となっています。世界中のヘルスケアシステムがリーンオペレーション、自動化、デジタル化をますます取り入れる中、単位用量製造は効率的な投薬管理の要として支持を集めています。製薬会社、医薬品製造受託機関（CMO）、医療機関は、経口固形剤から注射剤、吸入剤まで、多様な剤形に対応できる自動単位用量生産システムに投資しています。このフォーマットは、バーコードスキャン、電子カルテ（EHR）、投薬追跡システムとの互換性があり、その魅力をさらに高めています。規制機関がラベリング、トレーサビリティ、サプライチェーンの透明性に関する管理を強化する中、単位用量製造は現代の医薬品ロジスティクスに不可欠な要素として台頭してきています。

なぜ患者の安全と病院の効率化が単位用量包装の急増に拍車をかけているのか？

病院、診療所、外来ケアセンターは、医療ミスの削減、ワークフローの合理化、投薬プロセスの最適化というプレッシャーにさらされています。単位用量包装は、医療従事者による手作業を最小限に抑え、明確にラベル付けされ、不正開封が防止され、すぐに使用できる投薬単位を提供することで、これらの目標を直接支援します。このことは、特に入院病棟や救急外来など、一刻を争う薬剤投与とスタッフの作業負荷が大きな問題となる、大量の薬剤を扱う環境において重要です。また、単位用量フォーマットでは、ヘルスケアスタッフがバーコードを使用して正しい用量を迅速に確認できるため、交差汚染や誤投与の可能性が低くなります。さらに、投薬レジメンがますます個別化され複雑化する中、単位用量システムは、大量包装や手作業による調製に頼ることなく、個々の患者のニーズに合わせて治療を調整する柔軟性を提供します。正確な投与が特に重要である小児医療や老人医療では、単位用量ソリューションが安全性を向上させ、コンプライアンスを簡素化し、リスクを低減します。さらに、単位用量モデルは在庫管理と廃棄物の削減をサポートし、病院は医療の質を維持しながら医薬品コストを管理する方法を提供します。このような複合的な利点により、ヘルスケアプロバイダーは、急性期と慢性期の両方のケア提供モデルに単位用量形式を統合するよう促されており、その結果、医療機関全体の需要が加速しています。

自動化とスマート包装技術は単位用量製造を変えられるか？

技術革新は、単位用量製造の機能を拡大し、近代化する上で変革的な役割を果たしています。自動化が最前線にあり、包装ラインは現在、最小限の人的介入で個々のユニットの高速充填、ラベリング、シール、検査が可能です。ロボットシステムとAI対応の画像検査ツールは一貫した品質管理を保証し、モジュラー生産ラインは様々な剤形や包装仕様に対応するための迅速な再構成を可能にします。RFIDタグ、QRコード、時間-温度インジケーターなど、スマート包装技術も単位投与量フォーマットに組み込まれており、サプライチェーン全体を通じてリアルタイムの追跡と確認が可能です。これらの機能は、患者の安全性を高め、在庫の可視性を向上させ、偽造防止規制へのコンプライアンスをサポートします。病院EHRや薬局管理ソフトウェアとのデジタル統合により、処方、調剤、管理のシームレスな連携が可能になり、ミスの削減と効率化がさらに進みます。持続可能性の面では、メーカーは生分解性フィルムやリサイクル可能な材料を模索し、単位用量包装を環境目標に合致させようとしています。これらの進歩により、単位用量製造はより適応性が高く、効率的でインテリジェントなものとなり、製薬会社やヘルスケアシステムが安全性、トレーサビリティ、オペレーショナル・エクセレンスに対する進化する期待に応えられるよう支援しています。

世界単位用量製造市場の成長を促進するものは？

単位用量製造市場の成長は、テクノロジー統合、進化するヘルスケアプラクティス、規制力学、患者安全の必要性と密接に結びついたいくつかの要因によって牽引されています。中心的な成長要因は、正確な投薬とトレーサブルな調剤が最も必要とされる病院や長期ケア環境において、ミスのない自動投薬への世界のシフトです。また、外来患者や在宅ヘルスケアの拡大も、患者や介護者の煩雑さを軽減する、便利で計量済みの使い切り投薬フォーマットへの需要を後押ししています。製薬メーカーは、特にリスクの高い大量の医薬品について、社内業務に過度の負担をかけることなく需要に応えるため、単位用量生産を専門とするCMOとの提携を増やしています。医薬品のラベリング、連続化、安全性包装に関する規制の義務化は、特に北米と欧州で採用をさらに加速させています。これと並行して、パッケージングの自動化、スマートトラッキング、データ統合の技術的進歩により、拡張性が向上し、単位用量製造がより幅広い製薬企業にとって利用しやすくなっています。医療機関におけるコスト効率と廃棄物削減への注目が高まっていることも重要な要因であり、単位用量包装は在庫管理とリソースの最適化に効果的であることが証明されています。医療システムがより安全で効率的な薬物送達モデルを追求する中、これらの力が総合的に世界の単位用量製造市場の持続的成長を後押ししています。

セグメント

ソーシング（インハウス、アウトソーシング）;製品（液体単位用量、固体単位用量、その他）;エンドユース（独立薬局、長期療養施設、病院、その他）

調査対象企業の例

• Advanced Radiant Systems
• Advanced Distributor Products（ADP）
• Airtherm
• Armstrong International Inc.
• Beacon Morris
• Brasch Manufacturing Company, Inc.
• Daikin Industries Ltd.
• Detroit Radiant Products
• Dunham-Bush Limited
• Goodman Manufacturing
• Johnson Controls International Plc
• KING ELECTRICAL MFG. CO
• Kroll Energy GmbH
• Lennox International Inc.
• LG Electronics Inc.
• Marley Engineered Products
• Mitsubishi Electric Corporation
• Modine Manufacturing Company
• New York Blower Company
• Reznor（Nortek Global HVAC）
• Rheem Manufacturing Company
• Trane Technologies plc

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Unit Dose Manufacturing Market to Reach US$134.8 Billion by 2030

The global market for Unit Dose Manufacturing estimated at US$76.7 Billion in the year 2024, is expected to reach US$134.8 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. In-house, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$81.7 Billion by the end of the analysis period. Growth in the Outsourcing segment is estimated at 12.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.9 Billion While China is Forecast to Grow at 13.2% CAGR

The Unit Dose Manufacturing market in the U.S. is estimated at US$20.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.2 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Unit Dose Manufacturing Market - Key Trends & Drivers Summarized

Is the Shift Toward Precision Dosing Redefining the Pharmaceutical Packaging Landscape?

The rising emphasis on medication safety, dosing accuracy, and regulatory compliance is rapidly propelling the adoption of unit dose manufacturing across pharmaceutical and healthcare sectors. Unit dose packaging involves individually packaged and labeled doses of medications, typically designed for single-use, which enhances patient safety and reduces the risk of medication errors. This format has become especially crucial in hospital and long-term care settings where accurate dispensing plays a critical role in improving treatment outcomes and minimizing adverse drug events. With healthcare systems around the world increasingly embracing lean operations, automation, and digitization, unit dose manufacturing is gaining traction as a cornerstone of efficient medication management. Pharmaceutical companies, contract manufacturing organizations (CMOs), and healthcare institutions are investing in automated unit dose production systems that can handle diverse dosage forms-ranging from oral solids to injectables and inhalables. The format’s compatibility with barcode scanning, electronic health records (EHRs), and medication tracking systems further enhances its appeal. As regulatory bodies tighten controls around labeling, traceability, and supply chain transparency, unit dose manufacturing is emerging as an essential component of modern pharmaceutical logistics.

Why Are Patient Safety and Hospital Efficiency Fueling the Surge in Unit Dose Packaging?

Hospitals, clinics, and ambulatory care centers are under increasing pressure to reduce medical errors, streamline workflow, and optimize medication administration processes. Unit dose packaging directly supports these goals by providing clearly labeled, tamper-evident, ready-to-use medication units that minimize manual handling by healthcare providers. This is particularly significant in high-volume settings like inpatient wards and emergency rooms, where time-sensitive medication administration and staff workload are major concerns. Unit dose formats also allow healthcare staff to quickly verify correct dosages using barcodes, reducing the potential for cross-contamination or incorrect administration. Moreover, as medication regimens become increasingly personalized and complex, unit dose systems offer the flexibility to tailor treatments to individual patient needs without reliance on bulk packaging or manual preparation. In pediatric and geriatric care-where accurate dosing is especially critical-unit dose solutions improve safety, simplify compliance, and lower risk. Additionally, the unit dose model supports inventory control and waste reduction, offering hospitals a way to manage pharmaceutical costs while maintaining quality of care. These combined benefits are prompting healthcare providers to integrate unit dose formats into both acute and chronic care delivery models, thereby accelerating demand across institutional healthcare settings.

Can Automation and Smart Packaging Technologies Transform Unit Dose Manufacturing?

Technological innovation is playing a transformative role in scaling and modernizing unit dose manufacturing capabilities. Automation is at the forefront, with packaging lines now capable of high-speed filling, labeling, sealing, and inspection of individual units with minimal human intervention. Robotic systems and AI-enabled vision inspection tools ensure consistent quality control, while modular production lines allow rapid reconfiguration to accommodate various drug forms and packaging specifications. Smart packaging technologies are also being incorporated into unit dose formats, including RFID tags, QR codes, and time-temperature indicators, which enable real-time tracking and verification throughout the supply chain. These features enhance patient safety, improve inventory visibility, and support compliance with anti-counterfeiting regulations. Digital integration with hospital EHRs and pharmacy management software allows for seamless alignment between prescribing, dispensing, and administration, further reducing errors and increasing efficiency. On the sustainability front, manufacturers are exploring biodegradable films and recyclable materials to align unit dose packaging with environmental goals. These advancements are making unit dose manufacturing more adaptable, efficient, and intelligent-helping pharmaceutical companies and healthcare systems meet evolving expectations for safety, traceability, and operational excellence.

What Is Driving the Growth of the Global Unit Dose Manufacturing Market?

The growth in the unit dose manufacturing market is driven by several factors closely tied to technology integration, evolving healthcare practices, regulatory dynamics, and patient safety imperatives. A central growth driver is the global shift toward error-free, automated medication administration in hospitals and long-term care settings, where the need for accurate dosing and traceable dispensing is paramount. The expansion of outpatient and home healthcare services is also fueling demand for convenient, pre-measured, single-use medication formats that reduce complexity for patients and caregivers. Pharmaceutical manufacturers are increasingly partnering with CMOs specializing in unit dose production to meet demand without overburdening internal operations, especially for high-risk and high-volume drugs. Regulatory mandates on drug labeling, serialization, and safety packaging are further accelerating adoption, particularly in North America and Europe. In parallel, technological advances in packaging automation, smart tracking, and data integration are improving scalability and making unit dose manufacturing accessible to a wider range of pharmaceutical firms. Rising focus on cost efficiency and waste reduction in institutional settings is another key factor, with unit dose packaging proving effective in inventory control and resource optimization. As health systems pursue safer, more efficient medication delivery models, these forces are collectively propelling sustained growth in the global unit dose manufacturing market.

SCOPE OF STUDY:

The report analyzes the Unit Dose Manufacturing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sourcing (In-house, Outsourcing); Product (Liquid Unit Dose, Solid Unit Dose, Others); End-Use (Independent Pharmacies, Long Term Care Facility, Hospitals, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Advanced Radiant Systems
• Advanced Distributor Products (ADP)
• Airtherm
• Armstrong International Inc.
• Beacon Morris
• Brasch Manufacturing Company, Inc.
• Daikin Industries Ltd.
• Detroit Radiant Products
• Dunham-Bush Limited
• Goodman Manufacturing
• Johnson Controls International Plc
• KING ELECTRICAL MFG. CO
• Kroll Energy GmbH
• Lennox International Inc.
• LG Electronics Inc.
• Marley Engineered Products
• Mitsubishi Electric Corporation
• Modine Manufacturing Company
• New York Blower Company
• Reznor (Nortek Global HVAC)
• Rheem Manufacturing Company
• Trane Technologies plc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Unit Dose Manufacturing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Emphasis on Medication Accuracy and Patient Safety Drives Adoption of Unit Dose Packaging
  • Rising Demand for Hospital and Institutional Pharmacy Automation Strengthens Business Case for Unit Dose Manufacturing
  • Stringent Regulatory Requirements for Drug Traceability and Labeling Propel Market Growth
  • Expansion of Geriatric and Chronic Disease Populations Spurs Demand for Pre-Measured, Easy-to-Use Dosage Forms
  • Increased Focus on Reducing Medication Errors in Clinical Settings Accelerates Use of Unit Dose Systems
  • Growth in Outpatient and Home Healthcare Services Expands Need for Portable, Single-Dose Packaging
  • Technological Advancements in Packaging Machinery and Serialization Drive Efficiency and Compliance
  • Integration with Electronic Medical Records (EMR) and Barcode Systems Enhances Dose-Level Tracking
  • Adoption of Lean Manufacturing and Just-In-Time Inventory Strategies Supports Scalable Unit Dose Production
  • Pharmaceutical Companies' Shift Toward Patient-Centric Drug Delivery Models Fuels Demand for Unit Dose Formats
  • Global Push for Antimicrobial Stewardship and Infection Control Highlights Benefits of Single-Use Dosing
  • Emerging Markets' Healthcare Infrastructure Development Expands Opportunities for Unit Dose Deployment
  • Increased Outsourcing of Pharmaceutical Packaging Services Drives Specialized Unit Dose Contract Manufacturing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Unit Dose Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Unit Dose Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for In-house by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for In-house by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for In-house by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Liquid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Liquid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Liquid Unit Dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Solid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Solid Unit Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Solid Unit Dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Independent Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Independent Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Independent Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Long Term Care Facility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Long Term Care Facility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Long Term Care Facility by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Unit Dose Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Unit Dose Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Unit Dose Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Unit Dose Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Unit Dose Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Unit Dose Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Unit Dose Manufacturing by Sourcing - In-house and Outsourcing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Unit Dose Manufacturing by Sourcing - Percentage Breakdown of Value Sales for In-house and Outsourcing for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Unit Dose Manufacturing by Product - Liquid Unit Dose, Solid Unit Dose and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Unit Dose Manufacturing by Product - Percentage Breakdown of Value Sales for Liquid Unit Dose, Solid Unit Dose and Other Products for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Unit Dose Manufacturing by End-Use - Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Unit Dose Manufacturing by End-Use - Percentage Breakdown of Value Sales for Independent Pharmacies, Long Term Care Facility, Hospitals and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION